Log In
BCIQ
Print this Print this
 

COM701 (formerly CGEN-15029)

  Manage Alerts
Collapse Summary General Information
Company Compugen Ltd.
DescriptionB7/CD28-like immune checkpoint Fc fusion protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/18/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today